Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,865 | -68,061 | -46,915 | -28,754 | -51,015 |
| Depreciation Amortization | 923 | 726 | 535 | 288 | 1,324 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -182 |
| Accounts receivable | 149 | -39 | -167 | -45 | 4,898 |
| Accounts payable and accrued liabilities | 3,655 | 1,293 | -1,290 | 1,842 | -5,219 |
| Other Working Capital | -1,343 | -824 | -5,819 | -2,880 | -2,360 |
| Other Operating Activity | 35,347 | 31,846 | 29,203 | 17,317 | 13,921 |
| Operating Cash Flow | $-52,134 | $-35,059 | $-24,453 | $-12,232 | $-38,633 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -308 | -108 | -52 | N/A | -453 |
| Purchase Of Investment | -235,153 | -199,862 | -147,289 | -85,814 | -47,714 |
| Sale Of Investment | 67,829 | 41,514 | 26,557 | 10,500 | 54,554 |
| Investing Cash Flow | $-167,632 | $-158,456 | $-120,784 | $-75,314 | $6,387 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,483 | -11,483 | N/A | N/A | -137 |
| Common Stock Issued | 239,659 | 239,659 | 238,200 | 103,764 | 7,807 |
| Other Financing Activity | -3,124 | -3,122 | -1,579 | -3,014 | 10,702 |
| Financing Cash Flow | $225,052 | $225,054 | $236,621 | $100,750 | $18,372 |
| Beginning Cash Position | 22,063 | 22,063 | 22,063 | 22,063 | 35,937 |
| End Cash Position | 27,349 | 53,602 | 113,447 | 35,267 | 22,063 |
| Net Cash Flow | $5,286 | $31,539 | $91,384 | $13,204 | $-13,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,134 | -35,059 | -24,453 | -12,232 | -38,633 |
| Capital Expenditure | -308 | -108 | -52 | 0 | -453 |
| Free Cash Flow | -52,442 | -35,167 | -24,505 | -12,232 | -39,086 |